top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Drug Delivery Technology Development in Canada
Drug Delivery Technology Development in Canada
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (352 p.)
Disciplina 615.1/900971
Soggetto topico Medicine and Nursing
Soggetto non controllato 3D spheroid
adenanthin
amphotericin B
antibodies
bacteriophage
bioaccessibility
biodistribution
biological barriers
biologicals
blood-brain barrier
blood-brain barrier (BBB)
Canada
cancer
canola oil deodorizer distillate
cationic gemini surfactant
child friendly formulation
chronotherapy
circadian clock
cisplatin
clinical trials
co-delivery
combination therapy
controlled drug delivery
developing world
dissolution
DOX-Vit D
doxorubicin
drug delivery
drug delivery systems
drug development
drug discovery
drug-resistant melanoma
EGFR-targeted therapy
emulsion
encapsulation
flavonoids
formulation and dosage form development
fungal infections
gambogic acid
gastrointestinal simulator
GE11 peptide
HAV6 cadherin peptide
head and neck squamous cell carcinoma
HIF-1
hypoxia-induced chemoresistance
inclusion complex
innovation
intra-arterial chemotherapy
lipid nanoparticles
liposome
liposomes
loading gradients
magnetic fields
magnetic resonance imaging (MRI)
malignant gliomas
medical devices
medulloblastoma
mefloquine
melphalan
Metaplex
MG63
model orange juice
mouse models
nanoparticles
nifedipine
oral
oral delivery
oral formulation
parasitic infections
permeation enhancers
phage display
pharmaceutics
pharmacokinetics
pharmacological Inhibitors of HIF-1 and STAT3
phospholipid complex
photostabilizers
phytosterols
plant
polymeric micelle
precision medicine
primary central nervous system lymphomas
quercetin
radiation
radiolabeling
remote loading
ROESY NMR spectroscopy
rosmarinic acid
route of administration
skin
small molecules
STAT3
staurosporine
sustained delivery
targeted therapies
throughput
TNO gastrointestinal model
tocopherols
topical formulation
transdermal drug delivery
transient modulation
translational research
triggered drug release
ultrasound
virus
Vitamin D
water miscible solvents
ISBN 3-03928-005-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367736503321
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Regional Intestinal Drug Absorption : Biopharmaceutics and Drug Formulation
Regional Intestinal Drug Absorption : Biopharmaceutics and Drug Formulation
Autore Gonzalez-Alvarez Maria Isabel
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (238 p.)
Soggetto topico Manufacturing industries
Medicine and Nursing
Soggetto non controllato absorption-modifying excipients
BCS class IV drugs
BCS drugs
bioequivalence
biomimetic membrane
biopharmaceutics
biopharmaceutics classification system
Biopharmaceutics Classification System
clinical studies
colon absorption
combined zero- and first-order absorption
controlled release drug product
DDI
disintegration
dissolution
dissolution test
drug absorption
drug permeability
drug solubility
drug solubility/dissolution
drug-drug interactions
energy intake
enteric-coated
first-order absorption
first-pass effect
Franz cell
Franz-PAMPA
furosemide
gastrointestinal
gastrointestinal hormone
GastroPlus
hierarchical support vector regression (HSVR)
human colon carcinoma cell layer (Caco-2)
ibuprofen
ICH
in silico modeling
in situ perfusion
in vitro
in vitro in vivo extrapolations
intestinal absorption
intestinal perfusion
intestinal permeability
IVIVE
location-dependent absorption
manometry
mechanistic modeling
microdevices
mucoadhesion
nutrient absorption
nutrient digestion
obesity
oral absorption
oral drug delivery
oral peptide delivery
passive drug transport
PBBM
PBPK
permeation enhancers
pharmaceutical development
pharmacokinetics
Phoenix WinNonlin
physiologically-based pharmacokinetic (PBPK) modeling
postprandial glycaemia
pravastatin
quality control
region of the gut
regional intestinal permeability
regional/segmental-dependent permeability and absorption
route-dependent intestinal metabolism
segmental-dependent intestinal permeability
segregated flow intestinal model (SFM)
shape
traditional model (TM)
transit compartment absorption model
type 2 diabetes
zero-order absorption
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Regional Intestinal Drug Absorption
Record Nr. UNINA-9910566462603321
Gonzalez-Alvarez Maria Isabel  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Transmucosal Absorption Enhancers in the Drug Delivery Field
Transmucosal Absorption Enhancers in the Drug Delivery Field
Autore Maher Sam
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (406 p.)
Soggetto topico Medicine
Soggetto non controllato absorption enhancement
absorption enhancer
absorption enhancers
absorption modifying excipients
Aloe vera
amino acid
amphiphilic polymers
and liposome
antiepileptic drug
antimicrobial peptide
biocompatibility studies
bioenhancer
block copolymers
brush border
Caco-2
Caco-2 cells
cationic functionalization
cell-penetrating peptide
cell-penetrating peptide (CPP)
cervicovaginal tumors
chitosan
chitosan derivatives
claudin
clinical trial
CNS disorders
combined microsphere
compound 48/80
confocal laser scanning microscopy
cornea
curcumin
cyclodextrin
cytochrome P450
drug absorption enhancer
drug administration
drug delivery
efflux
enterocyte
epithelial permeability
epithelial transport
epithelium
F-actin
FITC-dextran
formulation
gel
gemini surfactant
GLP-1
hydrophobization
imatinib
in situ hydrogel
in vivo studies
insulin
intestinal absorption
intestinal delivery
intestinal epithelial cells
intestinal permeation enhancers
KLAL
man
mast cell activator
metabolism
mucoadhesion
mucoadhesiveness
N-dodecyl-?-D-maltoside (DDM)
nanocapsules
nanocrystals
nanomedicine
nanoparticle
nanoparticles
nasal
nasal delivery
nasal formulation
nasal permeability
nasal vaccination
nose to brain delivery
nose to brain transport
nose-to-brain
ocular conditions
ocular delivery
ocular drug delivery
ophthalmology
oral delivery
oral macromolecule delivery
oral peptides
osteoporosis
P-glycoprotein
penetration enhancer
penetration enhancers
permeability
permeation enhancer
permeation enhancers
pharmacokinetic interaction
pharmacokinetics
PN159
polymeric micelles
poorly absorbed drug
preclinical
PTH 1-34
pulmonary
quaternization
safety
salcaprozate sodium
sheep
simulated intestinal fluid
simvastatin
small intestine
sodium caprate
sodium cholate (NaC)
sugar-based surfactants
teriparatide
thermogel system
tight junction
tight junction modulator
tight junctions
transepithelial electrical resistance
transferrin
transmucosal drug delivery
transmucosal permeation
tryptophan
vaccine adjuvant
vaginal delivery
whole leaf
ISBN 3-03921-849-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910372785603321
Maher Sam  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui